Transforming your business with Microsoft Devices and the beenfits it can have for your business.

1. Transforming your business with
Microsoft Devices
Jo Baker
EUC Device and Tools Lead Nov 2016

2. Jo Baker
End User Computing, Device and Tools Lead
AstraZeneca
AstraZeneca is a global, science lead biopharmaceutical organisation, with over 50,000 staff.
As the Device and Tools lead working in End User Computing, Jo sources and evaluates new technology that
meets the requirements of the business.
Recommending devices to maximise productivity and minimise spend is a key part of his responsibilities,
working with the wider workplace teams to deliver the latest solutions to the business to help them meet and
exceed their goals.

3. The changing landscape of recording lab work
From sticky notes and paper to
electronic forms and direct note taking
From printed tables and scribbled numbers to
direct data recording in Excel and custom apps

4. The best fit for the requirements
Wipe clean screen
Detachable keyboard
Multiple input methods
Kickstand
Windows is still a better OS for legacy apps

5. Surface Pro 3: Electronic Lab Notebooks
650 devices deployed in 2015
Increase efficiency
Reduce error
Improve safety
Continued use after 12 months
Shift from companion to main device with Win10

6. Surface Pro 4: One device, multiple situations
It’s a Tablet
It’s also a Laptop
It’s a full time device and not a companion
It’s the right tool for the right job

7. Flexibility is Surface Pro4’s party trick
Touch and pen
Mouse and keyboard
Create, Consume, Collaborate, Showcase

8. Windows 10 – Because it’s not just about the device
Get your corporate build ready early
Applications working is one thing, how they work with the OS is the real goal
Work with your application vendors to ensure they’re Win10 ready, if not…
consider a change
Battery life / performance can be impacted if you get it wrong
Leverage your MSFT relationships

9. Confidentiality Notice
This file is private and may contain confidential and proprietary information. If you have received this file in error, please notify us and remove
it from your system and note that you must not copy, distribute or take any action in reliance on it. Any unauthorized use or disclosure of the
contents of this file is not permitted and may be unlawful. AstraZeneca PLC, 1 Francis Crick Avenue, Cambridge Biomedical Campus,
Cambridge, CB2 0AA, UK, T: +44(0)203 749 5000, www.astrazeneca.com
9